Your partner for Dx compliance in translational research

webinar

Article 5(5) Are you ready for the inhouse exemption

by James Lappin
Article 5(5) Are you ready for the in-house exemption

Article 5(5) Are you ready for the in-house exemption

Download our latest regulatory webinar, 'Article 5(5) Are you ready for the in-house exemption?'

Article 5(5) came into force on the 26th of may 2024 and considers several rules pertaining to the manufacturing and use of in-house medical devices, and the MDCG published its first Guidance of 2023 to guide and use the application of these rules.

With the exception of demonstrating conformity with general safety and personal requirements set out in Annex I, IVDR requirements do not apply to devices manufactured and used only within health institutions established in the Union, provided the conditions of Article 5(5) are met.

In this webinar, our SME, James Lappin, does a deep dive into the exemption provisions in Article 5(5) and discusses the following:

✅ What is the IVDR In-house exemption (Article 5(5))?
✅ How does it affect diagnostic testing in the EU, including local testing in clinical trials?
✅ What do you need to do to prepare?

Questions? Let us address your pain points: [email protected]

Please complete the form below to download our latest webinar 👇

 


James Lappin
Article written by James Lappin
CTA

Get in touch with our expert team today